Search for Clinical Trial Results
Cystadenocarcinoma - 74 Studies Found
Status | Study |
Completed |
Study Name: Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin Condition:
|
Completed |
Study Name: Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy Condition:
|
Completed |
Study Name: Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer Condition:
Interventions: |
Completed |
Study Name: A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Condition:
|
Completed |
Study Name: Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Condition:
|
Completed |
Study Name: Non Ivasive Prenatal Diagnosis (NIPD) of Cystic Fibrosis Condition: Noninvasive Mucinous Cystadenocarcinoma of Ovary Date: 2014-04-22 Interventions: Other: A sampling of blood A sampling of blood de 14 ml |
Terminated |
Study Name: Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm Condition:
Interventions: Drug: Ethanol and Paclitaxel Injection Endoscopic ultrasound will be used to locate and assess the pancr |
Active, not recruiting |
Study Name: Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer Condition:
|
Recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condition:
|
Terminated |
Study Name: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer Condition:
Interventions: |